Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.
about
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneityThe role of EMT and MET in cancer disseminationmiR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.TAT-ODD-p53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkin-mediated mitophagy.Hypoxia-induced angiotensin II by the lactate-chymase-dependent mechanism mediates radioresistance of hypoxic tumor cells.WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.Cancer Stem Cells: Plasticity Works against Therapy.Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy.Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells.Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.∆9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer.
P2860
Q26796292-1F85AD3B-ACFE-4F93-ACA7-6E0F093299A2Q26796298-C8FDDA9B-2595-4510-B875-1F898CD02D78Q33804175-94DEDF87-70ED-484E-B3A1-5971A80CFB60Q36232062-E68528D6-8A7D-42AA-A139-DF32A516FD4FQ37644348-A1A4D95B-2460-44F4-916B-FFB744555EE0Q37721627-BD26F444-9694-4833-9A7C-5A25CD4FF43AQ38707592-114A9F73-65D3-4065-8C2D-80540C8414C0Q38771479-696106E4-400D-48DF-A3A3-F29F57141D6BQ39069234-00327C0E-E648-4564-8323-8FB96194F886Q47130059-9B930CB9-65B3-4225-96E0-84F0E6AA0D31Q47552808-F2820BB2-9BE5-42A0-8158-A2365E0664FDQ50054318-5DF5E670-B12E-4FCF-8019-B58DA695260BQ55248912-283A5B67-4B3B-4791-9E7B-AFDCF3427778
P2860
Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumour-initiating capacity is ...... s in breast cancer cell lines.
@ast
Tumour-initiating capacity is ...... s in breast cancer cell lines.
@en
type
label
Tumour-initiating capacity is ...... s in breast cancer cell lines.
@ast
Tumour-initiating capacity is ...... s in breast cancer cell lines.
@en
prefLabel
Tumour-initiating capacity is ...... s in breast cancer cell lines.
@ast
Tumour-initiating capacity is ...... s in breast cancer cell lines.
@en
P2093
P2860
P356
P1476
Tumour-initiating capacity is ...... s in breast cancer cell lines.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.153
P407
P577
2014-04-22T00:00:00Z
P5875
P6179
1017928019